CausalSentinel

Protein Dossier — C1S (Complement C1s subcomponent)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Systolic blood pressure automated reading -0.0161 0.00478 7.33e-04 Wald ratio 1 trans NA
Forearm bone mineral density -0.102 0.0306 8.48e-04 Wald ratio 1 trans NA
Forced vital capacity (FVC) 0.0114 0.00383 0.00298 Wald ratio 1 trans NA
Mean cell haemoglobin concentration -0.0157 0.00661 0.0177 Wald ratio 1 trans NA
Diastolic blood pressure automated reading -0.0105 0.00478 0.0283 Wald ratio 1 trans NA
Clear cell ovarian cancer -0.17 0.0777 0.0286 Wald ratio 1 trans NA
Eye problems or disorders: Glaucoma 0.0773 0.0361 0.032 Wald ratio 1 trans NA
Bulimia nervosa -0.0283 0.0132 0.0321 Wald ratio 1 trans NA
Diagnoses - main ICD10: N20 Calculus of kidney and ureter 0.104 0.0502 0.0385 Wald ratio 1 trans NA
Non-cancer illness code self-reported: hayfever or allergic rhinitis -0.0403 0.02 0.0438 Wald ratio 1 trans NA
Diagnoses - main ICD10: C50 Malignant neoplasm of breast -0.0755 0.0394 0.0553 Wald ratio 1 trans NA
Sodium in urine -0.00874 0.00459 0.0568 Wald ratio 1 trans NA
…and 94 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3590_8_3 C1s Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

145 association rows across 100 traits (141 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Complement C1s subcomponent levels 3e-901 rs12146727 2 GCST90246772 no MR -> candidate analysis
Tyrosine-protein phosphatase non-receptor type 4 levels 5e-282 rs12146727 2 GCST90250026 no MR -> candidate analysis
Serum levels of protein CASQ1 4e-250 rs12146727 1 GCST90086646 no MR -> candidate analysis
Segment polarity protein dishevelled homolog DVL-2 levels 5e-221 rs12146727 1 GCST90247375 no MR -> candidate analysis
Serum levels of protein PTPN4 3e-146 rs12371227 1 GCST90087848 no MR -> candidate analysis
Blood protein levels 2e-144 rs16933084 8 GCST006585 no MR -> candidate analysis
Serum levels of protein PKN1 1e-132 rs12146727 1 GCST90087070 no MR -> candidate analysis
Calsequestrin-1 levels 1e-106 rs12146727 2 GCST90246821 no MR -> candidate analysis
Complement C1r subcomponent levels 6e-106 rs12146727 4 GCST90246770 no MR -> candidate analysis
Amyloid beta A4 precursor protein-binding family B member 2 7e-101 rs12146727 1 GCST90246533 no MR -> candidate analysis
Complement C1q subcomponent levels 3e-100 rs12368783 4 GCST90246760 no MR -> candidate analysis
SERPING1 protein levels 2e-93 rs12371227 1 GCST90470600 no MR -> candidate analysis
…and 88 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 412 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
Ehlers-Danlos syndrome, periodontal type 2 0.815 established (curated) no MR -> candidate analysis
complement component C1s deficiency 0.824 established (curated) no MR -> candidate analysis
Ehlers-Danlos syndrome, periodontitis type 0.681 established (curated) no MR -> candidate analysis
coronary artery disorder 0.809 common-variant locus no MR -> candidate analysis
immunodeficiency due to a classical component pathway complement deficiency 0.608 established (curated) no MR -> candidate analysis
hereditary disease 0.317 established (curated) no MR -> candidate analysis
placental retention 0.123 common-variant locus no MR -> candidate analysis
placenta praevia 0.07 common-variant locus no MR -> candidate analysis

Of the 8 rows above, 8 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 2 known modulators (Complement C1s subcomponent)
gnomAD constraint pLI=7.9e-06, LOEUF=0.775 — LoF-tolerant
GWAS Catalog 120 unique SNPs / 247 rows
ClinVar 772 records; 5 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance